These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 34169006)

  • 1. Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).
    Volpedo G; Pacheco-Fernandez T; Holcomb EA; Cipriano N; Cox B; Satoskar AR
    Front Cell Infect Microbiol; 2021; 11():685296. PubMed ID: 34169006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
    Zijlstra EE
    PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
    Zijlstra EE
    Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VL-HIV co-infection with Leishmania containing skin lesions resembling para-kala-azar dermal leishmaniasis.
    Alves NO; Oshiro JA; Silva YC; Pacher GC; Casaril AE; Rizk YS; Uehara SNO; Paniago AMM; Andrade ILX; Arruda CCP; Oliveira AG
    PLoS Negl Trop Dis; 2024 Aug; 18(8):e0012438. PubMed ID: 39186781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post kala-azar dermal leishmaniasis: A threat to elimination program.
    Gedda MR; Singh B; Kumar D; Singh AK; Madhukar P; Upadhyay S; Singh OP; Sundar S
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008221. PubMed ID: 32614818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.
    Trindade MA; Silva LL; Braz LM; Amato VS; Naafs B; Sotto MN
    BMC Infect Dis; 2015 Nov; 15():543. PubMed ID: 26592919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
    Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.
    Zijlstra EE; Alves F; Rijal S; Arana B; Alvar J
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005877. PubMed ID: 29145397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
    Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.
    Zijlstra EE; el-Hassan AM; Ismael A
    Am J Trop Med Hyg; 1995 Apr; 52(4):299-305. PubMed ID: 7741164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery.
    Hasan MM; Proma SB; Hossain MS; Arifuzzaman M; Islam N; Siddique MAB; Amiruzzaman
    BMC Infect Dis; 2023 Dec; 23(1):885. PubMed ID: 38110894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing clinico-epidemiology of post-kala-azar dermal leishmaniasis (PKDL) in India: Results of a survey in four endemic states.
    Saurabh S; Roy P; Pandey DK; Ray D; Tarak S; Pandey R; Kumar D; Jamil S; Paulraj A; Kumar A; Dutta S
    J Vector Borne Dis; 2020; 57(2):161-169. PubMed ID: 34290161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient.
    Routaray CB; Kumar A; Sundar S; Sathe G; Pawar H; Pai K
    Acta Parasitol; 2022 Jun; 67(2):687-696. PubMed ID: 35020128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmaniasis.
    Grevelink SA; Lerner EA
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):257-72. PubMed ID: 8642091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
    Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
    J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002-2011: a case series.
    Badirzadeh A; Mohebali M; Ghasemian M; Amini H; Zarei Z; Akhoundi B; Hajjaran H; Emdadi D; Molaei S; Kusha A; Alizadeh S
    Pathog Glob Health; 2013 Jun; 107(4):194-7. PubMed ID: 23816511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
    Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
    J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leishmaniases in Kenya: A scoping review.
    Grifferty G; Shirley H; O'Brien K; Hirsch JL; Orriols AM; Amechi KL; Lo J; Chanda N; El Hamzaoui S; Kahn J; Yap SV; Watson KE; Curran C; Atef AbdelAlim A; Bose N; Cilfone AL; Wamai R
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011358. PubMed ID: 37262045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the Post Kala-azar Dermal Leishmaniasis (PKDL) Consortium Meeting, New Delhi, India, 27-29 June 2012.
    Desjeux P; Ghosh RS; Dhalaria P; Strub-Wourgaft N; Zijlstra EE
    Parasit Vectors; 2013 Jul; 6():196. PubMed ID: 23819611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.